Literature DB >> 21536829

Insulin treatment for type 2 diabetes: when to start, which to use.

Marwan Hamaty1.   

Abstract

In type 2 diabetes mellitus, oral hypoglycemic agents and analogues of glucagon-like peptide-1 provide adequate glycemic control early in the disease. Insulin therapy becomes necessary for those with advanced disease. Further, some experts recommend electively starting insulin therapy in early diabetes. This review addresses practical approaches to insulin therapy, particularly when it is indicated and which regimen to use.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21536829     DOI： 10.3949/ccjm.78a.10051

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  10 in total

1.  Enhanced oral delivery of insulin via the colon-targeted nanocomposite system of organoclay/glycol chitosan/Eudragit®S100.

Authors:  Sang Hoon Lee; Seung-Yun Back; Jae Geun Song; Hyo-Kyung Han
Journal:  J Nanobiotechnology       Date:  2020-07-25       Impact factor: 10.435

Review 2.  Type 2 Diabetes Remission and Lifestyle Medicine: A Position Statement From the American College of Lifestyle Medicine.

Authors:  John Kelly; Micaela Karlsen; Gregory Steinke
Journal:  Am J Lifestyle Med       Date:  2020-06-08

3.  Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system.

Authors:  Jie Lin; Abegail Gill; Shelia H Zahm; Corey A Carter; Craig D Shriver; Joel A Nations; William F Anderson; Katherine A McGlynn; Kangmin Zhu
Journal:  Int J Cancer       Date:  2017-05-04       Impact factor: 7.396

4.  Barriers and facilitators to insulin treatment: a phenomenological inquiry.

Authors:  Ewunetie Mekashaw Bayked; Mesfin Haile Kahissay; Birhanu Demeke Workneh
Journal:  J Pharm Policy Pract       Date:  2022-07-19

5.  The "Life-World" trip of type 2 diabetes patients with allopathic treatment options: a triangulated qualitative investigation.

Authors:  Ewunetie Mekashaw Bayked; Mesfin Haile Kahissay; Birhanu Demeke Workneh
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 6.  Percutaneous coronary intervention in insulin-treated diabetic patients: A meta-analysis.

Authors:  Ying Ge; Daikun He; Yiru Shao; Lina Wang; Wei Yan
Journal:  Ann Noninvasive Electrocardiol       Date:  2022-04-25       Impact factor: 1.485

7.  Efficacy of oral versus insulin therapy for newly diagnosed diabetes in low-income settings.

Authors:  Elizabeth M Vaughan; Jennette P Moreno; David Hyman; Tzu-An Chen; John P Foreyt
Journal:  Arch Gen Intern Med       Date:  2017

8.  Clinical Insights Into a New, Disposable Insulin Delivery Device.

Authors:  P Gaye Knutsen; Cheryl Q Voelker; Carla C Nikkel
Journal:  Diabetes Spectr       Date:  2015-08

9.  BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin.

Authors:  Ariel Zisman; Francienid Morales; John Stewart; Andreas Stuhr; Aleksandra Vlajnic; Rong Zhou
Journal:  BMJ Open Diabetes Res Care       Date:  2016-04-13

Review 10.  Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures.

Authors:  Mengjie Wang; Chunxin Wang; Shuaikai Ren; Junqian Pan; Yan Wang; Yue Shen; Zhanghua Zeng; Haixin Cui; Xiang Zhao
Journal:  Int J Mol Sci       Date:  2022-03-20       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.